Con: Antifibrinolytics Are Not Safe and Effective in Patients Undergoing Liver Transplantation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 6, 2006, Pages 891-893

  Ramsay, Michael A E ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antifibrinolytics; aprotinin; epsilon aminocaproic acid; fibrinolysis; liver failure; liver transplantation; patient safety; thrombosis; tranexamic acid

Indexed keywords

EID: 33751347630     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.07.007     Document Type: Note

References (34)

1. Hedner U., and Erhardtsen E. Hemostatic disorders in liver diseases. In: Schiff E.R., Sorrell M.F., Maddrey W.C., et al. (Eds). Schiff's Diseases of the Liver (2003), Lippincott Williams & Wilkins, Philadelphia, PA 2003
2. Colucci M., Binetti B.M., Branca M.G., et al. Deficiency of thrombin-activatable fibrinolysis inhibitor in cirrhosis is associated with increased fibrinolysis. Hepatology 38 (2003) 230-237
3. Kelly D.A., and Tuddenham E.G. Hemostatic problems in liver disease. Gut 27 (1986) 339-349
4. Hersch S.L., Kunelis T., and Francis R.B. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: A critical role for tissue plasminogen activator inhibitor. Blood 69 (1987) 1315-1319
5. Tripodi A., Salerno F., Chantarangkul F., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
6. Bosch J., and Reverter J.C. The coagulopathy of cirrhosis: Myth or reality. Hepatology 41 (2005) 434-435
7. Kang Y.G., Martin D.J., Marquez J., et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 64 (1985) 888-896
8. Ben-Ari Z., Panagou M., Patch D., et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thromboelastography. J Hepatol 26 (1997) 554-559
9. Papatheodoridis G.V., Papakonstantinou E., Andrioti E., et al. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52 (2003) 404-409
10. Belli L., Romani F., Sansalone C.V., et al. Portal thrombosis in cirrhotics: A retrospective analysis. Ann Surg 203 (1986) 286-291
11. Porte R.J., Bontempo F.A., Knot E.A., et al. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 47 (1989) 978-984
12. Steib A., Gengenwin N., Freys G., et al. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 73 (1994) 645-648
13. Kang Y. Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation. Liver Transpl Surg 3 (1997) 655-659
14. Boylan J.F., Klinck J.R., Sandler A.N., et al. Tranexemic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85 (1996) 1043-1048
15. Kang Y., Lewis J.H., Navalgund A., et al. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 66 (1987) 7766-7773
16. Ramsay M.A.E. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation. Liver Transpl Surg 3 (1997) 665-674
17. Kaspar M., Ramsay M.A.E., Nguyen A.T., et al. Continuous small-dose tranexemic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg 85 (1997) 281-285
18. Dentz M.E., Slaughter T.F., and Mark J.B. Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon-aminocaproic acid. Anesthesiology 82 (1995) 583-586
19. Gologorsky E., De Wolf A.M., Scott V., et al. Intracardiac thrombosis formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 7 (2001) 783-789
20. Mallett S.V., Cox D., Burroughs A.K., et al. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. Lancet 336 (1990) 886-887
21. Neuhaus P., Bechstein W.O., Lefebre B., et al. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 14 (1989) 924-925
22. Porte R.J., Molenaar I.Q., Begliomini B., et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomized double-blind study. Lancet 355 (2000) 1303-1309
23. Bauer J., Futterman S., and Dreiling D.A. Anaphylactic shock secondary to initial trasylol administration. Am J Gastroenterol 56 (1971) 542-545
24. Ramsay M., and Randall H. Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?. Liver Transpl 10 (2004) 310-314
25. Baubillier E., Cherqui D., Dominique C., et al. A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 57 (1994) 1664-1666
26. Fitzsimons M.G., Peterfreund R.A., and Raines D.E. Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: Report of two cases. Anesth Analg 92 (2001) 1418-1421
27. Molenaar I.Q., Porte R.J., Fitzsimons M.G., et al. Aprotinin and thromboembolism in liver transplantation: Is there really a causal effect? Response. Anesth Analg 94 (2002) 1367-1368
28. Molenaar I.Q., Legnani C., Groenland T.H.N., et al. Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic effect. Liver Transpl 7 (2001) 896-903
29. Mangano D.T., Tudor I.C., Dietzel C., et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
30. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexemic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
31. Liu H., Song D., and Lee S.S. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 26 (2002) 842-847
32. Lentschener C., Roche K., and Ozier Y. A review of aprotinin in orthotopic liver transplantation: Can its harmful effects offset its beneficial effects?. Anesth Analg 100 (2005) 1248-1255
33. Ellis J.E., Lichtor J.L., Feinstein S.B., et al. Right-heart dysfunction, pulmonary embolism and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg 68 (1989) 777-782
34. Shore-Lesserson L., Manspeizer H.E., DePerio M., et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88 (1999) 312-319